European University Collaboration

International collaboration

The Master of Medicines Regulatory Affairs programme is a part of an international collaboration to unify and strengthen the post graduate education in Regulatory Affairs and Regulatory Science. 

The collaboration consists of the University of Copenhagen, University of Basel, University of Hertfordshire and King's College. The four universities offers in partnership the Master of European Medicines Regulatory Affairs.

This Masters programme will help both new and existing drug development professionals to ensure their work is in line with the latest developments in regulatory affairs.

Michel Goldman, Executive Director of Innovative Medicines Initiative

Relevant and international syllabus

As a part of the collaboration a common syllabus has been developed by a team representing the universities, experts from the pharmaceutical industry, regulatory authorities across Europe and professional societies in the PharmaTrain project of the Innovative Medicines Initiative (IMI).

This syllabus ensures you, that the master's programme is relevant in an international context.


The Master of European Regulatory Affairs is a part of the PharmaTrain, an IMI Education & Training project. The project focused on improving speedy medicines development through better and comprehensive training programmes.

PharmaTrain started 2009 as an Education and Training project within the European Innovative Medicines Initiative IMI (, the biggest public-private partnership in biomedicine.